RedSail Technologies company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former RedSail Technologies executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Key Business Breakdowns
Products & Services
PrimeCare
•••••• ••••-•••• •••• •••••••• •••••••••• •••••• ••• ••••• •••••••, ••••••• •••• •••••••••, •••••••••• •••••••••• •••••••, ••• •••• •••••••••••.
Integra
••••-•••• •••• •••••••• •••••••• ••••• (•••••••••• •• •••••••).
DocuTrack
•••••••• •••••••• •••••••••• •••••••• ••• ••• ••••••••••.
Network Solutions
•••••••••• ••••••• •••••••••• •• ••••••• •••••••• ••••••••, •••••••••••, ••• •••• •••••••.
RedSail Pay
•••••••• ••••••• •••••••••• ••••••• ••• ••••••••••.
QS/1
•••••••• •••••••••• •••••••• •••• •••••• •••••• ••• ••• ••••••••••.
Billing Switch Solution
•••••••• •••••• •••••••••/••••••• •••••••: •••••• ••••••••• •••••• ••• •••••••••••• •••••••.
Axys
•••-•••••, •••••-•••••• •••••••• •••••••••• •••••• ••• ••••••••••• ••• ••• ••••••••••.
PioneerRx
•••••••• •••••••••• •••••• ••• ••••••••••• ••• ••••••••• •••••••••• ••••••• •• •••••••••••• ••• •••• ••••••••••.
BestRx
••••••••• •••••••• •••••••••• •••••••• ••••• •••••• ••••••• •••••••••.
Pricing & Go-to-market
Typical Contract Length
••••-••••• •••••••••, ••••• ••••• •••••-••••• •••••••••••• •••••••• ••••••••• •••• • •. • •••• ••••.
Pricing model
••••••••••••-••••• ••••••• ••• •••• ••• ••••••••, •••• •••-••••••••••• •••• ••• •••••• •••••• ••• ••••••• •••••••••• ••••••••.
Average Sales Value
•. $•••• ••• •••• ••• ••••-•••• •••• ••••••••••, ••• •. $••• ••• •••• ••• ••••••••••• •••••• ••••••••••.
Average Sales Cycle
c. 2 months for cloud-based subscriptions and c. 3 months for traditional licenses, while both can be longer depending on factors such as customer siz• ••• ••••••••••.
Growth Review
Customer Overview
c. 12,000 customers, primarily within the retail and long-term care pharmacy verticals, with key segments including independent and small chains, univ•••••• •••••• •••••••, ••••••• •••••, ••••••••••••• ••• •••••••••••• ••••••••••.
Customer Concentration
••• ••• •. •% •• ••••••••• •••••••••• •• •. ••% •• ••••• •••••••.
Customer Retention
••-••%.
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 RedSail Technologies | - | ••• '•• | - | USA | P•••••••• |
 PrimeRx | - | - | - | - | - |
| | - | - | - | - | P••••• |
 SoftWriters | - | - | - | - | - |
Experts highlight RedSail Technologies's technical capabilities and platform strength, while noting market evolution and timing considerations as a potential constraint.
What does Origin provide on RedSail Technologies?
Origin provides a structured company snapshot of RedSail Technologies, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of RedSail Technologies different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how RedSail Technologies operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like RedSail Technologies?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like RedSail Technologies for investment, partnership, or competitive analysis.
Where does Origin's information on RedSail Technologies come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on RedSail Technologies?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to RedSail Technologies. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing RedSail Technologies?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like RedSail Technologies.
How can Origin support portfolio monitoring or add-on analysis for companies like RedSail Technologies?
For PE-backed contexts, Origin can support monitoring by surfacing changes in competitive intensity, customer demand signals, and go-to-market effectiveness. It can also inform add-on analysis by clarifying adjacency opportunities and how a target like RedSail Technologies may fit within a broader platform strategy.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like RedSail Technologies?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like RedSail Technologies, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
Castor
Modular software platform for clinical research organizations and trial sponsors to manage study design, patient recruitment, data collection, and trial monitoring activities for clinical trials.
HQ
Ownership
Investors
AiCure
AI-powered patient engagement and behavioral monitoring platform for clinical trials and life sciences organizations to confirm medication adherence, capture eCOA/ePRO, and predict dropout risk.